View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2030-05-17 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 750.00 |
| Coupon | 4.3 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 750 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Merck & Co Inc corporate note has a 4.30% fixed rate coupon paid on a semi-annual basis. It was issued on May 17, 2023 with an issue size of 750.00 million USD and matures on May 17, 2030 with a last coupon date of November 17, 2029. |
Merck & Co Inc, founded in 1891 and headquartered in Kenilworth, New Jersey, is a leading global healthcare company dedicated to the research, development, manufacturing, and marketing of prescription medicines, vaccines, biologic therapies, and animal health products. Notable products include the cancer immunotherapy Keytruda, the HPV vaccine Gardasil, and various treatments for cardiovascular and infectious diseases.